Project Details
Description
The DIRECT Consortium aims to discover and validate biomarkers that: (1) predict the rate of glycaemic deterioration before and after type 2 diabetes onset; (2) predict the response to diabetes therapies; and (3) help stratify type 2 diabetes into
clearly definable disease subclasses that can be treated more effectively.
clearly definable disease subclasses that can be treated more effectively.
| Short title | DIRECT |
|---|---|
| Acronym | IMI DIRECT |
| Status | Finished |
| Effective start/end date | 2012/05/16 → 2019/07/31 |
Collaborative partners
- Lund University (lead)
UKÄ subject classification
- Medical and Health Sciences